Boerner Christopher S.
- SEC CIK
- 0001543747
No open-market purchases or sales filed in the past year.
Current role at each company
- CL Colgate Palmolive CoDirectoras of May 13, 2026
- BMY Bristol Myers Squibb CoChief Executive Officeras of Mar 12, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Boerner Christopher S. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BMY Bristol Myers Squibb Co
Chief Executive Officer4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 21, 2025 (view filing) | Feb 20 | 1 day | Boerner Christopher S.Chief Executive Officer | PPurchaseCommon Stock, $0.10 par value | +2.00K | $55.05 | +$110.1K | +1.9%104.6K after | |
| Dec 7, 2023 (view filing) | Dec 5 | 2 days | Boerner Christopher S.Chief Executive Officer | PPurchaseCommon Stock, $0.10 par value | +2.00K | $49.78 | +$99.6K | +2.5%82.7K after | |
| Nov 30, 2023 (view filing) | Nov 28 | 2 days | Boerner Christopher S.Chief Executive Officer | PPurchaseCommon Stock, $0.10 par value | +3.07K | $48.86 | +$150.0K | +4.0%79.4K after | |
| Mar 16, 2022 (view filing) | Mar 14 | 2 days | Boerner Christopher S.EVP, Chief Commercial Officer | SSaleCommon Stock, $0.10 par value | −29.5K | $69.20 | −$2.04M | −41.3%42.0K after |